Paper38136141
Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress.
Lee D and 1 other. Antioxidants (Basel), 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress. Papers, record 38136141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136141
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022R1A2C1003890 (JHH) | National Research Foundation of Korea (NRF) grant funded by the Korean government | PubMed |
Source PubMed
References135
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27307437 | Structure of human Niemann-Pick C1 protein. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27307437 | PubMed |
| 2 | 12070301 | Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12070301 | PubMed |
| 3 | 34377675 | A neuropathological cell model derived from Niemann-Pick disease type C patient-specific iPSCs shows disruption of the p62/SQSTM1-KEAP1-NRF2 Axis and impaired formation of neuronal networks. | Mol Genet Metab Rep | 2021 | https://conductscience.org/library/papers/34377675 | PubMed |
| 4 | 36232960 | Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232960 | PubMed |
| 5 | 30709900 | Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells. | J Lipid Res | 2019 | https://conductscience.org/library/papers/30709900 | PubMed |
| 6 | 24188271 | Cyclodextrins and antioxidants. | Crit Rev Food Sci Nutr | 2014 | https://conductscience.org/library/papers/24188271 | PubMed |
| 7 | 27605553 | Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27605553 | PubMed |
| 8 | 28053186 | AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease. | J Lipid Res | 2017 | https://conductscience.org/library/papers/28053186 | PubMed |
| 9 | 16015597 | Adenovirus expressing an NPC1-GFP fusion gene corrects neuronal and nonneuronal defects associated with Niemann pick type C disease. | J Neurosci Res | 2005 | https://conductscience.org/library/papers/16015597 | PubMed |
| 10 | 31449799 | Repair or Lysophagy: Dealing with Damaged Lysosomes. | J Mol Biol | 2020 | https://conductscience.org/library/papers/31449799 | PubMed |
| 11 | 33329402 | From Inert Storage to Biological Activity-In Search of Identity for Oxidized Cholesteryl Esters. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33329402 | PubMed |
| 12 | 25206509 | Oxidative stress, mitochondrial damage and neurodegenerative diseases. | Neural Regen Res | 2013 | https://conductscience.org/library/papers/25206509 | PubMed |
| 13 | 31734384 | Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/31734384 | PubMed |
| 14 | 28658628 | The GARP Complex Is Involved in Intracellular Cholesterol Transport via Targeting NPC2 to Lysosomes. | Cell Rep | 2017 | https://conductscience.org/library/papers/28658628 | PubMed |
| 15 | 22120593 | Lysosomal vitamin E accumulation in Niemann-Pick type C disease. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22120593 | PubMed |
| 16 | 9499401 | Molecular chaperones as HSF1-specific transcriptional repressors. | Genes Dev | 1998 | https://conductscience.org/library/papers/9499401 | PubMed |
| 17 | 17989073 | Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein. | J Biol Chem | 2008 | https://conductscience.org/library/papers/17989073 | PubMed |
| 18 | 18216769 | Cellular cholesterol trafficking and compartmentalization. | Nat Rev Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18216769 | PubMed |
| 19 | 27551156 | Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection. | J Exp Med | 2016 | https://conductscience.org/library/papers/27551156 | PubMed |
| 20 | 32823559 | Adenovirus Reveals New Pathway for Cholesterol Egress from the Endolysosomal System. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32823559 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41901182 | The Simultaneous Prevention of Multiple Diseases: A "One Ring to Rule Them All" Framework for Redox-Driven Health and Longevity. | Nutrients | 2026 | https://conductscience.org/library/papers/41901182 | PubMed |
| 41900791 | Cyclodextrins as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900791 | PubMed |
| 41798938 | Case Report: Interleukin-23 blockade achieves sustained remission in Niemann-Pick type C-associated Crohn's disease refractory to anti-tumor necrosis factor therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41798938 | PubMed |
| 41720536 | Mass spectrometry-based lipid analysis in NPC1 disease: Methods for phosphoinositide quantification, lipid imaging, and myelin lipid profiling. | Methods Enzymol | 2026 | https://conductscience.org/library/papers/41720536 | PubMed |
| 41487968 | Integrative Machine Learning Analysis of Programmed Cell Death Pathways Identifies Novel Diagnostic Biomarkers for Atrial Fibrillation. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41487968 | PubMed |
| 41306917 | Epigenetic landscape in lysosomal storage disorders: mechanisms and modulation. | Front Genet | 2025 | https://conductscience.org/library/papers/41306917 | PubMed |
| 39263569 | Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39263569 | PubMed |
| 39099617 | Scientific opinion on the tolerable upper intake level for vitamin E. | EFSA J | 2024 | https://conductscience.org/library/papers/39099617 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136141
GET https://conductscience.org/api/papers/v1/38136141/references?page=2